“…Historically, such budget analyses were based solely on the acquisition cost of the drug being reviewed. Chang and others 1 showed that the cost of pharmacists' time required for dealing with nonformulary medication orders should also be considered. However, another important aspect of the formulary drug review process is the impact on the patient of changing a medication that is deemed (by hospital policies) to be nonformulary.…”